Author:
Tarlov Elizabeth,Stroupe Kevin T.,Lee Todd A.,Weichle Thomas W.,Zhang Qiuying L.,Michaelis Laura C.,Ozer Howard,Browning Margaret M.,Hynes Denise M.
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Bohlius J, Schmidlin K, Brillant C et al (2009) Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet 373(9674):1532–1542
2. Bohlius J, Tonia T, Schwarzer G (2011) Twist and shout: one decade of meta-analyses of erythropoiesis-stimulating agents in cancer patients. Acta Haematol 125(1–2):55–67
3. Wilson J, Yao GL, Raftery J et al (2007) A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment. Health Technol Assess 11(13):1-iv
4. Drugs@FDA. (Web site online). U.S. Department of Health & Human Services, U.S. Food and Drug Administration. Available at: http://www.accessdata.fda.gov/scripts/cder/drugsatfda . Accessed April 18, 2011
5. Henke M, Laszig R, Rube C et al (2003) Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 362(9392):1255–1260
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献